Cellectar Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.60
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
2
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.21
|
-1.28
|
-0.07
|
-5.79%
|
|
2022-06-30
|
-1.03
|
-1.22
|
-0.19
|
-18.45%
|
|
2022-03-31
|
-1.00
|
-1.00
|
0.00
|
0.00%
|
|
2021-12-31
|
-1.02
|
-0.90
|
0.12
|
11.76%
|
|
2021-09-30
|
-1.10
|
-1.00
|
0.10
|
9.09%
|
|
2021-06-30
|
-1.15
|
-1.10
|
0.05
|
4.35%
|
|
2021-03-31
|
-1.02
|
-1.30
|
-0.28
|
-27.45%
|
|
2020-12-31
|
-1.46
|
-0.70
|
0.76
|
52.05%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.50
|
|
2021-12-31
|
-4.30
|
|
2020-12-31
|
-5.22
|
|
2019-12-31
|
-1.97
|
|
2018-12-31
|
-6.06
|
|
2017-12-31
|
-10.70
|
|
2016-12-31
|
-13.09
|
|
2015-12-31
|
-1.10
|
|
2014-12-31
|
-1786.50
|
|
2013-12-31
|
-3900.39
|
|
2012-12-31
|
-1617.10
|
|
2011-12-31
|
-10388.79
|
|
2010-12-31
|
-457641.52
|
|
2009-12-31
|
-361755.53
|
|
2008-12-31
|
-1011395.14
|
|
2007-12-31
|
-401980.26
|
|
2006-12-31
|
-497950.90
|
|
2005-12-31
|
-230380.28
|